Laura H Porter
Dr Porter is an Early Career Research Fellow at Monash University in the Prostate Cancer Research Group, which has a strong translational focus that is applicable to urology and oncology clinical practice. Dr Porter’s expertise is in the use of patient-derived models of prostate cancer for studying tumour pathology and preclinical therapeutic testing. Her current research is focused on improving the efficacy of CAR T cell immunotherapy for the treatment of prostate cancer. CAR T cell therapy is a major advance in cancer treatment; however, its use in solid tumours has had limited success thus far. Her aim is to identify effective treatment strategies to overcome barriers for CAR T cell therapy that can be quickly translated into the clinic for patients with prostate cancer.
Abstracts this author is presenting:
